Neuroblastoma Immunotherapy by Paul M. Sondel, MD, PhD

Lecture by Paul M. Sondel, MD, PhD We are pursuing basic, preclinical and clinical mechanisms to induce in vivo activated innate immune effector cells to provide anti-tumor benefit.